Heimdall Insights

Global Hepatitis Therapeutics Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: July 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Hepatitis Therapeutics Market was valued at $17.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 4.1% CAGR, to an estimated market size of $21.4 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global hepatitis therapeutics market encompasses pharmaceutical treatments, vaccines, and disease management solutions for viral hepatitis (A, B, C, D, and E). The scope includes direct-acting antivirals (DAAs), nucleos(t)ide analogs, immunomodulators, and emerging novel therapeutic modalities such as siRNAs and capsid assembly modulators, while excluding diagnostic hardware and general hospital services.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Hepatitis Therapeutics Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Asia-Pacific
  • Europe
  • Rest of World

Segments

  • Hepatitis C
  • Hepatitis B
  • Other Hepatitis (A, D, E)